Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
18
TFX Quote, Financials, Valuation and Earnings
Last price:
$103.01
Seasonality move
:
5.49%
Day range:
$102.69 - $104.45
52-week range:
$102.58 - $185.94
Dividend yield:
1.32%
P/E ratio:
25.75x
P/S ratio:
1.46x
P/B ratio:
1.19x
Volume:
821.4K
Avg. volume:
868.1K
1-year change:
-43.24%
Market cap:
$4.6B
Revenue:
$3B
EPS (TTM):
-$7.36
Analysts' Opinion
-
Consensus RatingTeleflex, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $131.29, Teleflex, Inc. has an estimated upside of 27.46% from its current price of $103.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $115.00 representing 100% downside risk from its current price of $103.00.
Fair Value
-
According to the consensus of 10 analysts, Teleflex, Inc. has 27.46% upside to fair value with a price target of $131.29 per share.
TFX vs. S&P 500
-
Over the past 5 trading days, Teleflex, Inc. has underperformed the S&P 500 by -8.35% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Teleflex, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Teleflex, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Teleflex, Inc. reported revenues of $913M.
Earnings Growth
-
Teleflex, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Teleflex, Inc. reported earnings per share of -$9.24.
Enterprise value:
7B
EV / Invested capital:
--
Price / LTM sales:
1.46x
EV / EBIT:
12.25x
EV / Revenue:
2.18x
PEG ratio (5yr expected):
--
EV / Free cash flow:
26.30x
Price / Operating cash flow:
17.62x
Enterprise value / EBITDA:
8.18x
Gross Profit (TTM):
$1.7B
Return On Assets:
-4.43%
Net Income Margin (TTM):
-10.28%
Return On Equity:
-7.84%
Return On Invested Capital:
-5.23%
Operating Margin:
12.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $3B | $3B | $3.2B | $764.4M | $913M | |
| Gross Profit | $1.6B | $1.7B | $1.7B | $430.2M | $452.2M | |
| Operating Income | $572.5M | $547M | $567.4M | $144.2M | $113.3M | |
| EBITDA | $810M | $814M | $850.2M | $212.8M | $191.2M | |
| Diluted EPS | $8.54 | $5.03 | -$7.36 | $2.36 | -$9.24 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.5B | $2.1B | $1.5B | $2B | |
| Total Assets | $7B | $6.8B | $7.5B | $7.5B | $7.9B | |
| Current Liabilities | $562.2M | $610.9M | $585.4M | $618.8M | $773M | |
| Total Liabilities | $3.4B | $2.9B | $3.2B | $3B | $4.1B | |
| Total Equity | $3.7B | $3.9B | $4.3B | $4.5B | $3.8B | |
| Total Debt | $2.2B | $1.8B | $2.1B | $1.9B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $470.2M | $572.1M | $390.9M | $231M | $107.6M | |
| Cash From Investing | -$258.6M | -$639.8M | -$849.9M | -$21.2M | -$767.5M | |
| Cash From Financing | $258.9M | -$540.3M | $554M | -$174.8M | $756.3M | |
| Free Cash Flow | $379.9M | $450M | $264.3M | $209.8M | $77.7M | |
TFX
Sector
Market Cap
$4.6B
$26.2M
Price % of 52-Week High
55.39%
51.54%
Dividend Yield
1.32%
0%
Shareholder Yield
3.15%
-1.64%
1-Year Price Total Return
-43.24%
-16.92%
Beta (5-Year)
0.929
0.489
Dividend yield:
1.32%
Annualized payout:
$1.36
Payout ratio:
12.3%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$109.06
200-day SMA
Sell
Level
$122.20
Bollinger Bands (100)
Sell
Level
113.39 - 129.61
Chaikin Money Flow
Buy
Level
107.5M
20-day SMA
Sell
Level
$117.44
Relative Strength Index (RSI14)
Sell
Level
30.43
ADX Line
Sell
Level
26.63
Williams %R
Buy
Level
-98.7102
50-day SMA
Sell
Level
$116.58
MACD (12, 26)
Sell
Level
-4.43
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
51.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3947)
Buy
CA Score
(Annual)
Level (0.4862)
Buy
Beneish M-Score
(Annual)
Level (-2.8605)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.9977)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia, and Original Equipment Manufacturer and Development Services (OEM). The Americas, EMEA, and Asia segments are involved in the design, manufacture, and distribution of medical devices primarily used in critical care and surgical applications and generally serve two end-markets: hospitals and healthcare providers, and home health. The OEM segment refers to the design, manufacture, and supply of devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.
Stock Forecast FAQ
In the current month, TFX has received 0 Buy ratings 10 Hold ratings, and 0 Sell ratings. The TFX average analyst price target in the past 3 months is $131.29.
-
Where Will Teleflex, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Teleflex, Inc. share price will rise to $131.29 per share over the next 12 months.
-
What Do Analysts Say About Teleflex, Inc.?
Analysts are divided on their view about Teleflex, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Teleflex, Inc. is a Sell and believe this share price will drop from its current level to $115.00.
-
What Is Teleflex, Inc.'s Price Target?
The price target for Teleflex, Inc. over the next 1-year time period is forecast to be $131.29 according to 10 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is TFX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Teleflex, Inc. is a Hold. 10 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TFX?
You can purchase shares of Teleflex, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Teleflex, Inc. shares.
-
What Is The Teleflex, Inc. Share Price Today?
Teleflex, Inc. was last trading at $103.01 per share. This represents the most recent stock quote for Teleflex, Inc.. Yesterday, Teleflex, Inc. closed at $103.00 per share.
-
How To Buy Teleflex, Inc. Stock Online?
In order to purchase Teleflex, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TFX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TFX
Sector
P/E ratio
25.75x
23.89x
PEG ratio
--
-0.01x
P/B ratio
1.19x
1.81x
Price / LTM sales
1.46x
1.59x
Growth Metrics
TFX
Sector
Revenue growth
19.45%
4.35%
Earnings growth
-491.46%
9.8%
Revenue (5-year growth)
3.26%
6.41%
Earnings forecast
$3.78
-$0.18
Profitability
TFX
Sector
Profitability FY 2024
$1.7B
$3.2M
Return on invested capital
-5.23%
-32.76%
Return on assets
-4.43%
-29.32%
Return on equity
-7.84%
-38.6%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
TFX
Sector
Total cash
$368.7M
$25.4M
Short term investments
--
$25.1M
Total assets
$7.1B
$74.7M
Long term debt
$2.8B
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
